This paper examines schizophrenia as a chronic neuropsychiatric disorder affecting approximately 1% of the global population. It traces the disease's historical identification from ancient Egypt through Dr. Emile Kraepelin's 1887 classification and Eugen Bleuler's 1911 terminology. The paper categorizes symptoms into three types: positive symptoms (hallucinations, delusions, thought disorders, movement disorders), negative symptoms (flat affect, anhedonia, avolition, poverty of speech), and cognitive symptoms (executive dysfunction, attention deficits, memory impairment). It discusses the neurobiological basis of schizophrenia, including genetic factors and environmental triggers like early cannabis use. Treatment approaches encompass pharmacotherapy (typical and atypical antipsychotics) and psychosocial interventions (cognitive behavioral therapy and family therapy), with emphasis on the importance of continued medication adherence.
Have you ever been somewhere and heard someone nearby shouting obnoxious things to no one in particular? You may have witnessed a person experiencing symptoms of schizophrenia. Schizophrenia is a chronic, severe, and disabling brain disorder that has affected people throughout history. About 1 percent of the world's population lives with this illness today. Although schizophrenia is not commonly discussed in everyday conversation, it is in fact a very mysterious and interesting health problem that prompts questions about its history, symptoms, neurological mechanisms, and available treatments.
The word "schizophrenia" is less than 100 years old. However, the disease was first identified as a discrete mental illness by Dr. Emile Kraepelin in 1887, and the illness itself is generally believed to have accompanied humanity throughout its history. There may have been documents from ancient Egypt describing schizophrenia-like symptoms. The Book of Hearts, an ancient Egyptian text, expresses some symptoms of schizophrenia in great detail. According to historical records:
"Depression, dementia, as well as thought disturbances that are typical in schizophrenia.... The Heart and the mind seem to have been synonymous in ancient Egypt. The physical illnesses were regarded as symptoms of the heart and the uterus and originating from the blood vessels or from purulence, fecal matter, a poison or demons."
Ancient peoples held many misconceptions about the disease, attributing it to demonic possession or internal corruption. Whether schizophrenia existed before documented history and where it truly originated remains unknown. The Swiss psychiatrist Eugen Bleuler coined the term "schizophrenia" in 1911 and was also the first to describe symptoms as "positive" or "negative." The word itself derives from Greek roots: schizo (split) and phrene (mind), reflecting the fragmented thinking characteristic of the disorder.
Schizophrenia manifests through a wide array of symptoms affecting mental thoughts, physical behaviors, and perception. Almost all symptoms can resemble signs of other diseases or disorders, making diagnosis challenging. Symptoms fall into three distinct categories: positive symptoms, negative symptoms, and cognitive symptoms.
Positive symptoms include hallucinations, delusions, thought disorders, and movement disorders. Hallucinations occur when a person sees, feels, smells, or hears things that are fictional or not real. A person with schizophrenia may hear voices in their head either speaking to them or having conversations amongst themselves. Sometimes these voices command the person to act in certain ways or perform specific actions. A person may also feel something touch them that is not actually present or touch something they perceive but does not exist.
Delusions are similar to hallucinations but involve false beliefs rather than false perceptions. A person with delusions may believe that law enforcement agencies are pursuing them, that someone is constantly monitoring their movements, or that objects in their home have been converted into cameras or microphones. No matter how much evidence contradicts these beliefs, the person maintains conviction in them. As documented in clinical literature, a person with delusions "may also believe that people on television are directing special messages to them, or that radio stations are broadcasting their thoughts aloud to others. Sometimes they believe they are someone else, such as a famous historical figure."
Thought disorders involve unusual patterns of thinking and speech. A person may begin speaking and suddenly stop, having forgotten what they were about to say. Speech may become disorganized, stuttered, or labored. Individuals may also create neologisms—words without meaning—or insert nonsensical words into sentences. Movement disorders may involve repetitive motions, compulsive touching, or mild twitches. A rare movement disorder is catatonia, in which a person remains motionless and unresponsive to external stimuli for extended periods.
Negative symptoms include flat affect, anhedonia (lack of pleasure), avolition (lack of ability to initiate activities), and alogia (minimal or poverty of speech). Flat affect occurs when a person's facial expression remains immobile or their voice becomes dull and monotonous. Anhedonia means the person finds no excitement or enjoyment in daily life. Avolition involves difficulty initiating or completing activities; a person may plan an event but never follow through, or begin a project and fail to finish it. They lack motivation to engage in activities or maintain contact with others. Some individuals require assistance with basic hygiene and daily living tasks. Alogia is characterized by extremely limited speech and minimal interaction with others, even when prompted.
Cognitive symptoms include poor executive functioning, difficulty maintaining focus, and memory impairment. Executive functioning refers to the ability to understand information and use it to make sound decisions. A person with schizophrenia may struggle to concentrate on schoolwork, employment tasks, or their surroundings. This attention difficulty manifests differently across individuals. In the biography A Beautiful Mind by Sylvia Nasar, mathematician John Nash, who lived with schizophrenia, demonstrated different cognitive patterns early in life. His teacher believed he could not do the work, but his mother recognized that "he had merely found his own ways of solving problems." This case illustrates how attention deficits in schizophrenia can present as either distraction or alternative cognitive processing.
Memory problems are also common. Short-term memory loss can occur suddenly; a person may learn a skill and forget it within minutes. In her memoir The Center Cannot Hold: My Journey through Madness, psychologist Elyn R. Saks describes experiencing additional symptoms beyond the typical presentation. She noted becoming preoccupied with health concerns, interpreting minor physical symptoms as potentially fatal illnesses. This hypochondriacal tendency represents a symptom variant not seen in all schizophrenia cases. The diversity of symptom presentation makes accurate diagnosis difficult for medical professionals.
The human brain maintains delicate neurochemical balance, and even minor defects can profoundly affect functioning. The precise neurobiological mechanisms underlying schizophrenia remain incompletely understood. Which brain regions trigger the behaviors seen in schizophrenia? How do auditory hallucinations and compulsions to vocalize arise? These questions remain difficult for clinicians to answer definitively. No comprehensive information exists about which brain areas show increased or decreased activity in patients with schizophrenia. Numerous clinical studies have investigated various factors affecting brain function in schizophrenia, including the effects of cannabis and marijuana use. Research indicates that heavy marijuana use during early life increases the likelihood of developing schizophrenia.
Schizophrenia is predominantly caused by genetic inheritance; a family history of the disease is the strongest predictor of risk. Many cases appear between ages 20 and 24. Heredity, rather than other environmental or medical causes, accounts for the vast majority of diagnoses. Understanding these genetic and environmental risk factors remains an active area of psychiatric research.
Treatment of schizophrenia has advanced significantly over the past century. Because the underlying causes remain unknown, therapeutic interventions focus on symptom reduction. Treatment modalities include antipsychotic medications and psychosocial interventions, collectively known as pharmacotherapy and psychotherapy. Two categories of antipsychotic medications exist: typical (original) antipsychotics and atypical (newer-generation) antipsychotics.
Commonly used typical antipsychotics include Chlorpromazine (Thorazine), Haloperidol (Haldol), Perphenazine (Etrafon, Trilafon), and Fluphenazine (Prolixin). During the 1990s, second-generation or "atypical" antipsychotics were developed, offering improved efficacy with potentially fewer side effects. Clozapine is an atypical medication that effectively treats hallucinations and other positive symptoms. However, clozapine can rarely cause agranulocytosis, a serious condition involving depletion of infection-fighting white blood cells that requires close medical monitoring.
Psychosocial treatments complement pharmacotherapy. Cognitive behavioral therapy is a brief form of psychotherapy based on the principle that thought patterns influence behavior and emotional outcomes. Family therapy is particularly valuable when the patient is a child or adolescent; it helps both the individual and their family understand the disease, manage symptoms in home settings, and navigate interactions with medical, educational, and social agencies. Family therapy and pharmacotherapy together represent the most commonly employed treatment combination. Numerous support programs exist to help individuals manage schizophrenia effectively. Persons with schizophrenia should never discontinue treatment or medication without medical guidance, as doing so can result in serious relapse or death.
Schizophrenia is a dangerous illness capable of causing progressive brain deterioration. It is a group of disorders characterized by withdrawal from reality, illogical thought patterns, delusions, and hallucinations. Although current knowledge does not fully answer all questions about the disease's history, symptoms, neurobiological basis, and treatment options, researchers worldwide continue to investigate this condition. The search for a cure for schizophrenia is far from complete. Research laboratories and charitable organizations globally are working toward achieving multiple goals in the fight against schizophrenia, advancing understanding and improving outcomes for those affected.
You’re 98% through this paper. Sign up to read the full paper.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.